SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-136370
Filing Date
2020-12-16
Accepted
2020-12-16 17:01:08
Documents
13
Period of Report
2020-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2038680d1_8k.htm   iXBRL 8-K 29907
2 EXHIBIT 10.1 tm2038680d1_ex10-1.htm EX-10.1 85198
  Complete submission text file 0001104659-20-136370.txt   315320

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adap-20201216.xsd EX-101.SCH 3196
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20201216_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20201216_pre.xml EX-101.PRE 22717
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2038680d1_8k_htm.xml XML 3690
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 201393129
SIC: 2836 Biological Products, (No Diagnostic Substances)